PlasmAr

es convalescent plasma compared with placebo, improve patients’ clinical status at 30 days?
Continue reading »A compendium of critical appraisals in Intensive Care Medicine research and related specialties
es convalescent plasma compared with placebo, improve patients’ clinical status at 30 days?
Continue reading »In adult trauma patients presenting with signs of haemorrhagic shock does the utilisation of a viscoelastic haemostatic assay (VHA) augmented transfusion strategy compared to a strategy augmented by conventional coagulation tests (CCT) result in an increased number of patients alive and free of massive transfusion at 24 hours?
Continue reading »In patients with acquired thrombocytopenia purport, does calpacizumab compared with placebo, reduce the time to normalisation of the platelet count?
Continue reading »In patients with acute intracerebral haemorrhage, associated with antiplatelet therapy, does platelet transfusion compared with standard care reduce death or dependence?
Continue reading »